Volume 61, Issue 9 pp. 2782-2787
CASE REPORT

Prolonged incubation period of hepatitis B in a recipient of a nucleic acid amplification test-negative hepatitis B virus window donation

Takahiro Matsuno

Takahiro Matsuno

Department of Blood Transfusion, Fujita Health University Hospital, Toyoake, Aichi, Japan

Search for more papers by this author
Hideaki Matsuura

Hideaki Matsuura

Department of Blood Transfusion, Fujita Health University Hospital, Toyoake, Aichi, Japan

Department of Molecular Laboratory Medicine, Fujita Health University School of Medical Sciences, Toyoake, Aichi, Japan

Search for more papers by this author
Sumie Fujii

Sumie Fujii

Department of Transfusion Medicine and Cell Therapy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Search for more papers by this author
Ami Tanaka

Ami Tanaka

Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan

Search for more papers by this author
Masahiro Satake

Masahiro Satake

Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan

Search for more papers by this author
Tomohiro Kinoshita

Tomohiro Kinoshita

Japanese Red Cross Aichi Blood Center, Seto, Aichi, Japan

Search for more papers by this author
Akihiro Tomita

Akihiro Tomita

Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Search for more papers by this author
Yusuke Matsui

Yusuke Matsui

School of Public Health, Division of Infectious Diseases and Vaccinology, University of California, Berkeley, California, USA

Search for more papers by this author
Yukari Sugiura

Corresponding Author

Yukari Sugiura

Department of Blood Transfusion, Fujita Health University Hospital, Toyoake, Aichi, Japan

Correspondence

Yasuo Miura and Yukari Sugiura, Department of Blood Transfusion, Fujita Health University Hospital, 1–98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470–1192, Japan.

Email: [email protected] (Y. M.) and [email protected] (Y. S.)

Search for more papers by this author
Yasuo Miura

Corresponding Author

Yasuo Miura

Department of Blood Transfusion, Fujita Health University Hospital, Toyoake, Aichi, Japan

Department of Transfusion Medicine and Cell Therapy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Correspondence

Yasuo Miura and Yukari Sugiura, Department of Blood Transfusion, Fujita Health University Hospital, 1–98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470–1192, Japan.

Email: [email protected] (Y. M.) and [email protected] (Y. S.)

Search for more papers by this author
First published: 14 July 2021
Citations: 2

Funding information: Fujita Health University

Abstract

Background

The occurrence of transfusion-transmitted hepatitis B virus (HBV) infection has fallen dramatically due to continuous improvements in pre-transfusion laboratory testing. However, the characteristics of transfusion-transmitted HBV infection caused by individual donor nucleic acid amplification test (ID-NAT)-negative blood products are unclear.

Case Presentation

A 76-year-old woman with acute myeloid leukemia was diagnosed with transfusion-transmitted HBV infection after receiving apheresis platelets derived from an ID-NAT-negative blood donation. This case was diagnosed definitively as transfusion-mediated because complete nucleotide homology of a 1556 bp region of the HBV Pol/preS1-preS2-S genes and a 23 bp region of the HBV core promoter/precore between the donor and recipient strains was confirmed by PCR-directed sequencing. The case is uncommon with respect to the unexpectedly prolonged HBV-DNA incubation period of nearly 5 months after transfusion (previously, the longest period observed since the recent implementation of ID-NAT pre-transfusion laboratory testing in Japan was 84 days). Slow-replicating HBV genotype A2 may contribute to the prolonged incubation period; also, the quantity of apheresis platelets delivered in a large volume of plasma, and/or the immune response of the recipient suffering from a hematological neoplasm, may have contributed to establishment of HBV infection in the recipient. This was supported by analysis of three previously documented cases of transfusion-transmitted HBV infection by blood products derived from ID-NAT-negative donations in Japan.

Conclusion

Continuous monitoring of HBV infection for longer periods (>3 months) may be required after transfusion of blood components from an ID-NAT-negative HBV window donation.

CONFLICT OF INTEREST

The authors have disclosed no conflicts of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.